viernes, 2 de agosto de 2013

GlaxoSmithKline now admits executives involved in criminal bribery, days after denials

GlaxoSmithKline now admits executives involved in criminal bribery, days after denials



                  
First came the denials, then - finally - the admission that, yes indeed, some of GlaxoSmithKline's senior Chinese executives broke the law in a $484.8 million cash and sexual favors scandal.